With the Alpha Trial steadily approaching, did you know? This trial is focused on improving women's health in rural KwaZulu-Natal, South Africa. This pilot study is set to validate a novel colposcope for dual screening of FGS and cervical cancer. #WomensHealth#AlphaTrial#FGS
Excited about our research on diagnosing Female Genital Schistosomiasis! Working with QCELL and Prof. Balas, weβre testing the innovative SAVE-MMC alpha device in our upcoming clinical trial. This tool promises better diagnosis and effective treatment. #MedicalResearch#FGS
Journey Through Time: Key Milestones in Female Genital Schistosomiasis Research! From the discovery in the 1900s to the latest advancements in the 2020s, explore our timeline and see how far we've come. #Schistosomiasis#PublicHealth#FGS#Research
Don't miss out on our latest podcast episode featuring Takalani Nemungadi discussing vital research on female genital schistosomiasis! Listen now by clicking the link in our bio and share with others. Stay tuned for Episode 2! #FGS#HealthAwareness#PodcastListeners
Unlocking insights in our new podcast series with our first guest Takalani Nemungadi, WHO's Infectious Hazard Management Officer in South Africa. Dive into her groundbreaking research, including the DualSave study, and unravel the complexities of Female Genital Schistosomiasis.
Predictors for Mass-Treatment Participation! π Dive into this study to discover the factors influencing community involvement in treatment programs for Schistosomiasis. Together, we can make a difference! https://t.co/L937btS35e #SchistoControl#ResearchFindings
#DYK that #Schistosomiasis affects millions but remains largely hidden. @sighsavers research in Ondo State π³π¬ reveals the critical role of community trust in tackling this NTD. Every story matters in the fight to #BeatSchisto. #BeatNTDs#FGSchisto
https://t.co/9tETGkxymp
Worldwide efforts demonstrate a unified commitment to eliminating schistosomiasis as a public health threat, highlighting the importance of treating entire communities, including young children, by 2030. https://t.co/ue4G12G5tr
Attending (online) the #EDCTPForum "Partnering for Global Health Research Innovation and Impact in Africa β Celebrating EDCTP: two decades and beyond" with Andrea J. Hult. Best online conference experience @FGSnoMore@EDCTP@EDCTP3@EUScienceInnov@uiagder
Genital infections are extremely common around the world. In endemic schistosomiasis areas, FGS is the 2nd most common Infection after HSV. Learn MORE ABOUT FGS and other genital tract infections in our new Scientific Paper. https://t.co/8laLAx7BVS. #FGS#femalehealthcare
Did you know? Female Genital Schistosomiasis is a neglected disease affecting women in endemic regions. π Let's empower communities with knowledge of prevention methods like safe water practices and promote early treatment through mass drug administration. #WorldNTDDay#FGS
On #WorldNTDDay, let's shed light on Female Genital Schistosomiasis - a neglected tropical disease affecting millions. πΊπ Join the fight against #FGS by raising awareness, supporting research, and advocating for better healthcare. Together, we can make a difference! ππ¦
π Welcoming 2024 with a renewed commitment to end Female Genital Schistosomiasis! Cheers to health, happiness, and impactful achievements in the New Year! π₯β¨ #NewYear2024#EndFGS#GlobalHealth#HopefulBeginnings
FGS Unveiled! πIn Volume 12 of the Continuous Textbook of Womenβs Medicine, explore the silent impact of Female Genital Schistosomiasis on 56M+ women in Sub-Saharan Africa. Authors: Steben M, Kjetland EF, et al. π #FGSAwareness#HealthInsights#SandyPatches π